Drug Shortage Report for DOSTINEX
| Report ID | 73569 |
| Drug Identification Number | 02242471 |
| Brand name | DOSTINEX |
| Common or Proper name | DOSTINEX |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | CABERGOLINE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 8's |
| ATC code | G02CB |
| ATC description | OTHER GYNECOLOGICALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-01-24 |
| Estimated end date | 2019-09-20 |
| Actual end date | 2019-09-09 |
| Shortage status | Resolved |
| Updated date | 2019-09-10 |
| Company comments | Distributed by Paladin. Limited inventory available and on preventative allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-01-25 | English | Compare |